Compare HALO & CTRE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | HALO | CTRE |
|---|---|---|
| Founded | 1998 | 2013 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 8.8B | 9.0B |
| IPO Year | 2001 | 2013 |
| Metric | HALO | CTRE |
|---|---|---|
| Price | $61.63 | $37.25 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 11 | 9 |
| Target Price | ★ $78.18 | $42.44 |
| AVG Volume (30 Days) | 1.3M | ★ 2.0M |
| Earning Date | 05-05-2026 | 04-30-2026 |
| Dividend Yield | N/A | ★ 3.60% |
| EPS Growth | N/A | ★ 96.25 |
| EPS | ★ 2.56 | 1.57 |
| Revenue | $151,862,000.00 | ★ $476,393,000.00 |
| Revenue This Year | $28.24 | $5.47 |
| Revenue Next Year | $12.79 | $11.16 |
| P/E Ratio | $24.74 | ★ $23.75 |
| Revenue Growth | N/A | ★ 60.79 |
| 52 Week Low | $47.50 | $25.82 |
| 52 Week High | $82.22 | $41.72 |
| Indicator | HALO | CTRE |
|---|---|---|
| Relative Strength Index (RSI) | 30.59 | 36.15 |
| Support Level | $61.23 | $35.39 |
| Resistance Level | $65.40 | $38.27 |
| Average True Range (ATR) | 1.54 | 1.00 |
| MACD | -0.06 | -0.36 |
| Stochastic Oscillator | 1.27 | 13.70 |
Halozyme Therapeutics Inc is a biotechnology company focused on developing and commercializing novel oncology therapies. The company seeks to create therapies focused on human enzymes that alter tumors. Halozyme focuses on developing its proprietary products in therapeutic areas with a focus on oncology, and licensing its technology to biopharmaceutical companies to collaboratively develop products. The company's operations are based in the United States, with minimal long-lived assets located internationally.
CareTrust REIT Inc is a self-administered, publicly traded REIT engaged in the ownership, acquisition, financing, development, and leasing of skilled nursing, seniors housing, and other healthcare-related properties. The company has one reportable segment consisting of investments in healthcare-related real estate assets. It generates revenues by leasing healthcare-related properties to healthcare operators under triple-net lease arrangements, in which the tenant is solely responsible for property-related costs. The company operates in Domestic and Foreign markets, with the majority of revenue coming from Domestic operations.